Clinical Trials Logo

Clinical Trial Summary

Occipital neuralgia and subsequent headaches are associated with significant morbidity and impact quality of life and ability to work. Treatment is primarily medical and consists of non-steroidal anti-inflammatory medications and medications to treat neuropathic pain. Many patient exhaust medical management options and suffer from persistent symptoms. Surgical management of chronic headaches including occipital neuralgia is emerging as a tool to relieve pain and the burden of morbidity associated with this condition. Dr. Bahman Guyuron has been reporting positive results in the literature for the past 20 years. In a systematic review of 14 papers it has been demonstrated that peripheral nerve surgery for migraines is effective and leads to an improvement of symptoms for 86% of patients. Complication rates were low across all studies included. Additionally, Dr Ivica Ducic has reported success specifically treating occipital neuralgia headaches, with significant improvements in subjective pain outcomes post-operatively. The mechanism behind this is thought to be similar to carpal tunnel syndrome, whereby peripheral nerve compression causes nerve irritation and pain. The ensuing inflammatory response to tissue injury can cause sensitization of nociceptors, resulting in hyperalgesia or allodynia. Surgical release of tight surrounding soft tissues results in nerve decompression and relief of symptoms. Although there are multiple case series and empiric evidence supporting the safety and efficacy of occipital migraine surgery, there are no randomized controlled studies comparing surgical intervention with continued medical management. As part of the present study, the investigators intend to randomize patients who have exhausted maximal medical treatment of post-traumatic occipital headaches to either a surgical management group or a continued medical management group. Surgical intervention will consist of neurolysis, or release, of the occipital nerves.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03253523
Study type Interventional
Source Rush University Medical Center
Contact
Status Withdrawn
Phase N/A
Start date September 30, 2019
Completion date February 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06247592 - Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients N/A
Recruiting NCT05491915 - The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain N/A
Completed NCT01753765 - Study Evaluating the Treatment of Occipital Neuralgia N/A
Completed NCT01988363 - Greater Occipital Nerve Injection Study Phase 1
Completed NCT03478735 - Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block N/A
Not yet recruiting NCT04124458 - Occipital Nerve RF Between Occipital Nerve Block And Occipital Nerve Radiofrequency Ablation N/A
Completed NCT06458179 - Ultrasound Guided Radiofrequency Ablation of Proximal Greater Occipital Nerve in Primary Occipital Neuralgia
Completed NCT04051203 - Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia Phase 1
Completed NCT01670825 - Pulsed Radiofrequency vs. Steroid Injections for Occipital Neuralgia N/A
Terminated NCT03475797 - Evaluation of Occipital Nerve Stimulation in Intractable Occipital Neuralgias N/A